Frazier Life Sciences Management, L.P. Revolution Medicines, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 997,455 shares of RVMD stock, worth $67.6 Million. This represents 1.97% of its overall portfolio holdings.
Number of Shares
997,455
Previous 997,455
-0.0%
Holding current value
$67.6 Million
Previous $36.7 Million
26.94%
% of portfolio
1.97%
Previous 1.94%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
355Shares Held
195MCall Options Held
2.66MPut Options Held
945K-
Vanguard Group Inc Valley Forge, PA15.7MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.6MShares$991 Million2.96% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$908 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.4MShares$769 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA9.81MShares$665 Million0.08% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.94B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...